Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linaclotide vs Senna in CIC
NCT02239510Terminated
- Sponsor
- TriHealth
- Start
- Sep 2014
- Primary completion
- Jun 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial of linaclotide in chronic idiopathic constipation (CIC) (2 arms), sponsored by TriHealth. Primary endpoint: Change in Number of Bowel Movements Per Week at 12 weeks. Started Sep 2014; status: terminated.
02
Drugs
linaclotide
03
Conditions
chronic idiopathic constipation (CIC)
Beyond the preview
Go deeper on NCT02239510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02239510.